30 closest matches · ranked by relevance
Adult Solid Neoplasm · Toxicity · Lymphoma
Primary: Patient Experienced Any Grade 3-5 Toxicity — 0.51; 0.71 proportion of participants — p=0.0001
Cancer
Primary: Number of Experts Who Considered That the Question "Do You Live Alone ?" Should be Retained in the G-CODE — 42 Participants
Dependency
Primary: Dependence in Activities of Daily Living — 78; 77 Participants
Pain
Primary: Reduction of Pain Score at 30 Minutes — 4.4; 4.2 score on a scale
Intensive Care Unit Syndrome
Primary: Feasibility of Bundle Delivery — 50 Participants
Lymphoma · Digestive System Diseases · Ovarian Diseases
Primary: Number of Participant Deaths — 56 Participants
Generalized Anxiety Disorder
Primary: Comparisons of End of Study HAM-A Score Means for Sertraline 50 mg vs Placebo, Sertraline 100 mg vs Placebo, and Sertraline 50 mg vs. Sertraline 100 mg — 10.638; 10.008…
Prostate Specific Antigen · Asymptomatic Bacteriuria · Type 2 Diabetes Mellitus
Primary: Misuse of Urinalysis or Urine Culture in Older Women — 25 Participants
Anaesthesia
Primary: Number of Participants With Successful Laryngeal Mask Placement — 26; 20; 6; 11 Participants
SURGICAL PROCEDURES, OPERATIVE · Aged · Epidemiology
Primary: Number of Participants With All-Cause Mortality at 90-days — 103; 6172 Participants
Ageing
Primary: CRM Performance During First Sim Scenario Assessed by Ottawa Global Rating Scale (GRS) — -0.299 Pearson correlation coefficient — p=0.039
Hematologic Malignancy
Primary: Overall Survival — 79; 49 Participants
Major Depressive Disorder
Primary: Hamilton Depression Rating Scale (HDRS) — 17.2; 16.6; 7.6; 7.5 units on a scale
Gastric Cancer
Primary: 2-month Response Rate — 25 percentage of participants
Bipolar Disorder · Depression, Bipolar
Primary: Assessment of Change in Depressive Symptoms From Baseline on the Montgomery Asberg Depression Rating Scale (MADRS) — -15.5 units on a scale — p=<.01
Adult Acute Myeloid Leukemia · Secondary Acute Myeloid Leukemia · Therapy-Related Acute Myeloid Leukemia
Primary: Rate of Complete Remission and Mortality in the Entire Cohort of Older Patients — 21.9; 52.0 percentage of subjects
Prostate Specific Antigen Screening · Asymptomatic Bacteriuria · Type 2 Diabetes
Primary: PSA Screening in Older Men — 1675; 1373 Participants
Aging
Primary: Change in Microbiome — 0; 0; 0 Operational Taxonomic Unit (OTU)
HIV Positive · Ageing
Primary: The Prevalence of Reported Aches and Pains in the Last Month Across the 3 Age Groups — 473; 224; 188 participants
Aging · Hyperthermia
Primary: Log Lactulose/Rhamnose Following Control Trial — 0.97; 0.79 Ratio
Anxiety Disorders · Generalized Anxiety Disorder
Primary: Response Using Clinical Global Impressions-Improvement Scale (CGI-I) — 51; 69 participants
Adult Solid Neoplasm · Lymphoma
Primary: Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology…
Diabetes · Hyperglycemia
Primary: Percent of Participants With a Mean Blood Glucose Concentration of Less Than 70 mg/dL — 28; 31 percentage of participants
Bipolar Depression
Primary: Mean Glutamine to Creatine Ratio by Diagnosis at Baseline — .34; .36 mean serum Glutamine to Creatine ratio
Mild Cognitive Impairment (MCI) · Depression
Primary: Change in Hamilton Depression Rating Scale — 17.8; 17.7; 6.0; 6.7 units on a scale
Chronic Disease
Primary: PROMIS Global Health Measure Score — 46.27; 46.21; 44.92; 46.38 T-score
Multiple Myeloma · Myeloma · Disability Physical
Primary: Intervention Attendance (Feasibility) — 50 percentage of participants
Major Depressive Disorder
Primary: Hamilton Depression Rating Scale (HDRS) Scores 24 — 17.88; 19.92; 6.86; 10.33 units on a scale
Pulmonary Disease
Primary: Number of Cases With Fever (Body Temperature Reach 38 Degree Celsius or Higher) — 0; 2 participants
Elderly · Epilepsy · Seizures
Primary: Effectiveness of Medication as Measured by Participation Through the End of the Trial. — 14 participants